Tata Kadiatou Traore
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Tata Kadiatou Traore has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Salfo Ouedraogo
Research and Development Laboratory for Phytomedicines and Drugs (LR-D/PM), Institute for Research in Health Sciences (IRSS/CNRST), Ouagadougou, Burkina Faso; Laboratory of Drug Development (LADME), Joseph Ki-Zerbo University, Ouagadougou, Burkina Faso
6 shared publications - Boladé Constantin Atchade
Laboratory for Drug Development (LADME), Center for Training, Research and Expertise in Drug Sciences (CEA-CFOREM), Doctoral School of Health Sciences (ED2S), Joseph KI-ZERBO University, BP-7021, Burkina Faso. Phytomedicine and Drug Research and Development Laboratory (LR-D/PM), Health Sciences Research Institute (IRSS), National Center for Scientific and Technological Research (CNRST) BP 7047 Ouagadougou 03, Burkina Faso
5 shared publications - Rasmané Semdé
Centre de Formation, de Recherche et d’Expertises en sciences du médicament (CEA-CFOREM), Université Joseph KI-ZERBO, Ouagadougou, Burkina Faso
4 shared publications - Sylvin Ouedraogo
Département Médecine et Pharmacopée Traditionnelles – Pharmacie (MEPHATRA-PH), Institut de Recherche en Sciences de la Santé/Centre National de la Recherche Scientifique et Technologique (IRSS/CNRST), Ouagadougou, Burkina Faso
3 shared publications - Florent Wendinmi Bertrand Goumbri
Research and Development Laboratory for Phytomedicines and Drugs (LR-D/PM), Institute for Research in Health Sciences (IRSS/CNRST), Ouagadougou, Burkina Faso
2 shared publications - Lazare Belemnaba
Département Médecine et Pharmacopée Traditionnelles – Pharmacie (MEPHATRA-PH), Institut de Recherche en Sciences de la Santé/Centre National de la Recherche Scientifique et Technologique (IRSS/CNRST), Ouagadougou, Burkina Faso
2 shared publications
Latest Publications
- 30 September 2026
- Published by Informatics Publishing Limited in Journal of Natural Remedies
- Vol. 2026 (9) , 2251-2269
Therapeutic Potential of Ampelocissus africana (Lour.) Merr. (Vitaceae) Underutilised and Indigenous Vegetables: Merging Traditional and Scientific Knowledge
Background: Ampelocissus africana is a plant widely distributed in Africa. A. africana is used in food through its rhizomes and fruits, but also in traditional medicine for its ability to cure a wide range of human diseases. Aim: This review provides an overview of traditional, phytochemical, pharmacological, toxicological, and galenic knowledge regarding the use of A. africana. Methods: Online databases such as Google Scholar, PubMed, ScienceDirect, and African Journals Online (AJOL) were used to identify relevant research on the plant. ChemDraw Professional 15.0® was used to generate the chemical structure of the compounds present in the different parts of the plant. Results:: Ampelocissus africana has demonstrated therapeutic potential through pharmacological testing in several pathologies such as malaria, bacterial/fungal infections, benign prostatic hyperplasia, dermatoses, diseases with inflammatory components, diabetes, and sickle cell disease. Different classes of bioactive compounds have been identified, isolated, and quantified. Eight compounds were isolated from the rhizomes and leaves: β-sitosterol, betulin, 15-hydroxymethyl-16-methylheptadecyl ferulate, 3-hydroxymethyl-5-methyl-16-oxoheptadecyl ferulate, luteolin, derivatives of isorhamnetin and quercetin, and 1-O-β-D-rhamnopyranosyl-4-ethylphenylbut-2-one. Experimental studies have shown that Ampelocissus africana possesses significant anti-inflammatory, antioxidant, anxiolytic, antimalarial, antifungal, antisickling, haemolytic and anti-benign prostatic hyperplasia activity in both in vitro and in vivo models. Toxicological studies on the extracts have proven their safety. The rhizome powder of this plant is used as an excipient in the manufacture of tablets. Conclusion: This literature review provides a solid scientific foundation to guide future research on A. africana Major Findings: Ampelocissus africana exhibits a range of pharmacological activities, primarily attributed to the presence of various molecules belonging to the terpene, sterol and phenolic compound classes. However, further research is needed to better understand its effects, confirm its therapeutic value and accurately assess any potential risks associated with its use.
- 30 September 2026
- Published by Informatics Publishing Limited in Journal of Natural Remedies
- Vol. 2026 (9) , 2251-2269
Therapeutic Potential of Ampelocissus africana (Lour.) Merr. (Vitaceae) Underutilised and Indigenous Vegetables: Merging Traditional and Scientific Knowledge
Background: Ampelocissus africana is a plant widely distributed in Africa. A. africana is used in food through its rhizomes and fruits, but also in traditional medicine for its ability to cure a wide range of human diseases. Aim: This review provides an overview of traditional, phytochemical, pharmacological, toxicological, and galenic knowledge regarding the use of A. africana. Methods: Online databases such as Google Scholar, PubMed, ScienceDirect, and African Journals Online (AJOL) were used to identify relevant research on the plant. ChemDraw Professional 15.0® was used to generate the chemical structure of the compounds present in the different parts of the plant. Results:: Ampelocissus africana has demonstrated therapeutic potential through pharmacological testing in several pathologies such as malaria, bacterial/fungal infections, benign prostatic hyperplasia, dermatoses, diseases with inflammatory components, diabetes, and sickle cell disease. Different classes of bioactive compounds have been identified, isolated, and quantified. Eight compounds were isolated from the rhizomes and leaves: β-sitosterol, betulin, 15-hydroxymethyl-16-methylheptadecyl ferulate, 3-hydroxymethyl-5-methyl-16-oxoheptadecyl ferulate, luteolin, derivatives of isorhamnetin and quercetin, and 1-O-β-D-rhamnopyranosyl-4-ethylphenylbut-2-one. Experimental studies have shown that Ampelocissus africana possesses significant anti-inflammatory, antioxidant, anxiolytic, antimalarial, antifungal, antisickling, haemolytic and anti-benign prostatic hyperplasia activity in both in vitro and in vivo models. Toxicological studies on the extracts have proven their safety. The rhizome powder of this plant is used as an excipient in the manufacture of tablets. Conclusion: This literature review provides a solid scientific foundation to guide future research on A. africana Major Findings: Ampelocissus africana exhibits a range of pharmacological activities, primarily attributed to the presence of various molecules belonging to the terpene, sterol and phenolic compound classes. However, further research is needed to better understand its effects, confirm its therapeutic value and accurately assess any potential risks associated with its use.
- Open Access
- 16 August 2026
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 16 (8) , 52-64
Physicochemical and microbiological characteristics of Calotropis procera Ait. root bark powders from 20 sites in Burkina Faso for standardization
Calotropis procera is a component of the phytomedicine FACA®, used to manage sickle cell disease in Burkina Faso. This work aimed to standardize plant powders by evaluating the physicochemical characteristics and microbial quality of Calotropis procera root bark powders from different sites, with properties similar to those of the reference harvest site, to optimize the production of the phytomedicine. The samples were collected from different geographical areas of Burkina Faso during the dry season. The population, physicochemical characteristics, and microbial quality of each powder were evaluated. Twenty (20) geolocated harvest sites were identified with various soil types (clay, silt, gravel, and sand). The availability of Calotropis procera was high in Ziniaré, Ouaga 1, and Boromo; average across 8 sites; and low across 9. Physicochemical analyses of the powders revealed general uniformity in pH and residual moisture content. However, differences were observed in color, bitterness, and hygroscopicity. Total phenolics could serve as tracers, given their content is comparable to that of the reference. All samples complied with the specifications of the European Pharmacopeia 11th edition for total aerobic bacteria, yeasts and molds, and E. coli. Pathogens such as Salmonella and Staphylococcus aureus have been found in some powders. This study identified the optimal sites for collecting Calotropis procera samples. Keywords: Sickle cell disease; Calotropis procera; root bark; geographical variability.
- 16 August 2026
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 16 (8) , 52-64
Open AccessPhysicochemical and microbiological characteristics of Calotropis procera Ait. root bark powders from 20 sites in Burkina Faso for standardization
Calotropis procera is a component of the phytomedicine FACA®, used to manage sickle cell disease in Burkina Faso. This work aimed to standardize plant powders by evaluating the physicochemical characteristics and microbial quality of Calotropis procera root bark powders from different sites, with properties similar to those of the reference harvest site, to optimize the production of the phytomedicine. The samples were collected from different geographical areas of Burkina Faso during the dry season. The population, physicochemical characteristics, and microbial quality of each powder were evaluated. Twenty (20) geolocated harvest sites were identified with various soil types (clay, silt, gravel, and sand). The availability of Calotropis procera was high in Ziniaré, Ouaga 1, and Boromo; average across 8 sites; and low across 9. Physicochemical analyses of the powders revealed general uniformity in pH and residual moisture content. However, differences were observed in color, bitterness, and hygroscopicity. Total phenolics could serve as tracers, given their content is comparable to that of the reference. All samples complied with the specifications of the European Pharmacopeia 11th edition for total aerobic bacteria, yeasts and molds, and E. coli. Pathogens such as Salmonella and Staphylococcus aureus have been found in some powders. This study identified the optimal sites for collecting Calotropis procera samples. Keywords: Sickle cell disease; Calotropis procera; root bark; geographical variability.
- Open Access
- 28 July 2026
- Published by Science Publishing Group in Pharmaceutical Science and Technology
- Vol. 10 (2) , 32-41
Development of Lozenges from Fruit Extract of Balanites aegyptiaca (L) Delile (Zygophyllaceae) for the Treatment of Occasional Constipation
Balanites aegyptiaca (L.) Del. is a plant whose fruit pulp is traditionally used to treat constipation. They possess inherent laxative properties. This study aimed to improve upon the traditional method of use by developing lozenges with these laxative properties. An infusion was performed, and the physicochemical characteristics of the lyophilized extract were determined. The lozenges were formulated from the extract, and their quality and laxative efficacy in vivo were controlled in NMRI strain mice. The extract was yellow, had a bitter-sweet taste, a characteristic smell, and a fine texture. The pH was 5.56, and the RMC was 1.16%. The powder was highly hygroscopic, and the extraction yield was 33.71%, with a saponoside content of 2.76 μgED/mg. Fifteen (15) formulations were prepared, and formulation F7 was selected for the incorporation of the extract. The F7 was yellow, sweet, with an uncharacteristic odor and a hard appearance. The lozenges were uniform (1.95±0.04 g), with an average pH of 5.85±0.07 and a saponoside content of 2.01±0.26 μgED/mg. The lozenges had an accelerated intestinal transit percentage of 75.74±3.22%, comparable to that of the extract (78.10±4.32%) and castor oil (81.84±9.46%). After slowing down transit with loperamide (45.24±2.38%), the lozenges (60.84±7.13%) brought the percentage close to normal transit (65.94±3.33%). This study highlighted the laxative efficacy of lozenges made from Balanites aegyptiaca fruit pulp extract.
- 28 July 2026
- Published by Science Publishing Group in Pharmaceutical Science and Technology
- Vol. 10 (2) , 32-41
Open AccessDevelopment of Lozenges from Fruit Extract of Balanites aegyptiaca (L) Delile (Zygophyllaceae) for the Treatment of Occasional Constipation
Balanites aegyptiaca (L.) Del. is a plant whose fruit pulp is traditionally used to treat constipation. They possess inherent laxative properties. This study aimed to improve upon the traditional method of use by developing lozenges with these laxative properties. An infusion was performed, and the physicochemical characteristics of the lyophilized extract were determined. The lozenges were formulated from the extract, and their quality and laxative efficacy in vivo were controlled in NMRI strain mice. The extract was yellow, had a bitter-sweet taste, a characteristic smell, and a fine texture. The pH was 5.56, and the RMC was 1.16%. The powder was highly hygroscopic, and the extraction yield was 33.71%, with a saponoside content of 2.76 μgED/mg. Fifteen (15) formulations were prepared, and formulation F7 was selected for the incorporation of the extract. The F7 was yellow, sweet, with an uncharacteristic odor and a hard appearance. The lozenges were uniform (1.95±0.04 g), with an average pH of 5.85±0.07 and a saponoside content of 2.01±0.26 μgED/mg. The lozenges had an accelerated intestinal transit percentage of 75.74±3.22%, comparable to that of the extract (78.10±4.32%) and castor oil (81.84±9.46%). After slowing down transit with loperamide (45.24±2.38%), the lozenges (60.84±7.13%) brought the percentage close to normal transit (65.94±3.33%). This study highlighted the laxative efficacy of lozenges made from Balanites aegyptiaca fruit pulp extract.
- Open Access
- 7 November 2025
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 388-394
FORMULATION AND CHARACTERIZATION OF EFFERVESCENT TABLETS FROM A TRADITIONAL MEDICINE RECIPE FOR DENTAL CARE
Objective: Plant use to treat pathologies is increasingly common in Africa. Our study focuses on a recipe (active ingredient) of traditional medicine that has proven itself in treating dental caries and oral pathologies. This study aims to formulate and evaluate the quality of effervescent tablets based on the recipe (active ingredient) for treating dental caries and oral hygiene. Methods: A physicochemical and pharmacotechnical characterization of the recipe (RMC, pH, Hausner index, Carr index, flow rate) was carried out. Five stoichiometric ratios of the citric acid/sodium bicarbonate combination were used (1:3.32; 1:3.11; 1:3; 1:2.93; 1:2.87). The tablets were obtained after wet granulation. Pharmacotechnical tests were carried out according to the European Pharmacopoeia 10th Ed to determine the most optimal formulation that could promote rapid release of the active ingredient. Results: The recipe constituting the active ingredient has properties with an apparent density of 0.50, and a density after tamping of 0.65. The compressibility index is 23.61, and the Hausner index is 1.30. These fairly weak rheological properties required improvement through granulation. A total of 5 formulations were obtained. Formulations F2 to F5 had a disintegration time of less than 5 min. The friability rate was less than 4.60%, 0.86%, 0.91%, 0.75%, and 1.22 for the formulations respectively F1 to F5 and the hardness 95N, 81.8N, 118N, 103.6N, 89.8N. The stoichiometric ratio of 1:3.11 gave us the most optimal formulation with a disintegration time of 156 seconds, a friability rate of 0.86%, and a pH of 5.13. Conclusion: These results demonstrate the feasibility of a solid form to be redispersed for use in oral hygiene.
- 7 November 2025
- Published by Innovare Academic Sciences Pvt Ltd in International Journal of Applied Pharmaceutics
- p. 388-394
Open AccessFORMULATION AND CHARACTERIZATION OF EFFERVESCENT TABLETS FROM A TRADITIONAL MEDICINE RECIPE FOR DENTAL CARE
Objective: Plant use to treat pathologies is increasingly common in Africa. Our study focuses on a recipe (active ingredient) of traditional medicine that has proven itself in treating dental caries and oral pathologies. This study aims to formulate and evaluate the quality of effervescent tablets based on the recipe (active ingredient) for treating dental caries and oral hygiene. Methods: A physicochemical and pharmacotechnical characterization of the recipe (RMC, pH, Hausner index, Carr index, flow rate) was carried out. Five stoichiometric ratios of the citric acid/sodium bicarbonate combination were used (1:3.32; 1:3.11; 1:3; 1:2.93; 1:2.87). The tablets were obtained after wet granulation. Pharmacotechnical tests were carried out according to the European Pharmacopoeia 10th Ed to determine the most optimal formulation that could promote rapid release of the active ingredient. Results: The recipe constituting the active ingredient has properties with an apparent density of 0.50, and a density after tamping of 0.65. The compressibility index is 23.61, and the Hausner index is 1.30. These fairly weak rheological properties required improvement through granulation. A total of 5 formulations were obtained. Formulations F2 to F5 had a disintegration time of less than 5 min. The friability rate was less than 4.60%, 0.86%, 0.91%, 0.75%, and 1.22 for the formulations respectively F1 to F5 and the hardness 95N, 81.8N, 118N, 103.6N, 89.8N. The stoichiometric ratio of 1:3.11 gave us the most optimal formulation with a disintegration time of 156 seconds, a friability rate of 0.86%, and a pH of 5.13. Conclusion: These results demonstrate the feasibility of a solid form to be redispersed for use in oral hygiene.
- Open Access
- 15 September 2025
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 15 (9) , 73-82
Evaluation of toxicity, antispasmodic, and analgesic activities of Improved Traditional Medicine (ITM) based on Diospyros mespiliformis and Combretum micranthum indicated in the treatment of gastrointestinal disorders
This study focused on an improved traditional herbal medicine (ITHM) used in capsule form for the treatment of gastrointestinal disorders. This study aimed to investigate the phytochemistry, toxicity, and pharmacological activity of the ITM. ITM and extracts underwent phytochemical characterization tests and their dosages. Antioxidant, antispasmodic and analgesic properties and acute toxicity study were realized. Bioactive compounds, including flavonoids, saponins, tannins, etc. were detected. The total phenolic of the ITM were higher with 109.02±0.15 mg EAT/g. The highest total flavonoid content was obtained by the decocted with 17.04±0.25 mg EQ/g and ITM with 16.91± 0.80 mg EQ/g. ITM had the best antioxidant activity by the DPPH method with an IC50 of 24.65 ± 1.05 µg/ml; the decocted had the best activity by the ABTS method with an IC50 of 12.86 ± 0.95 µg/ml and the extracts and ITM had significantly the same activities by LPO method, hence the choice of ITM for the rest of the pharmacological activity. ITM has a low toxicity and an estimated LD50 of 5000 mg/kg. The maximum antispasmodic effect of ITM at the maximum concentration of 3.98 mg/mL was 87.30% with an effective concentration 50 (EC50) of 0.66±0.05 mg/mL. The analgesic effect of ITM was dose-dependent, with inhibition percentages at the dose of 50 mg/kg of 59.82%, that of 100 mg/kg of 64.73% and that of 150 mg/kg of 71.43%. The results on ITM provide a scientific basis for its use in the management of gastric pathologies. Keywords: ITM; Phytochemicals; Antioxidants; Acute toxicity; Antispasmodic; Analgesic.
- 15 September 2025
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 15 (9) , 73-82
Open AccessEvaluation of toxicity, antispasmodic, and analgesic activities of Improved Traditional Medicine (ITM) based on Diospyros mespiliformis and Combretum micranthum indicated in the treatment of gastrointestinal disorders
This study focused on an improved traditional herbal medicine (ITHM) used in capsule form for the treatment of gastrointestinal disorders. This study aimed to investigate the phytochemistry, toxicity, and pharmacological activity of the ITM. ITM and extracts underwent phytochemical characterization tests and their dosages. Antioxidant, antispasmodic and analgesic properties and acute toxicity study were realized. Bioactive compounds, including flavonoids, saponins, tannins, etc. were detected. The total phenolic of the ITM were higher with 109.02±0.15 mg EAT/g. The highest total flavonoid content was obtained by the decocted with 17.04±0.25 mg EQ/g and ITM with 16.91± 0.80 mg EQ/g. ITM had the best antioxidant activity by the DPPH method with an IC50 of 24.65 ± 1.05 µg/ml; the decocted had the best activity by the ABTS method with an IC50 of 12.86 ± 0.95 µg/ml and the extracts and ITM had significantly the same activities by LPO method, hence the choice of ITM for the rest of the pharmacological activity. ITM has a low toxicity and an estimated LD50 of 5000 mg/kg. The maximum antispasmodic effect of ITM at the maximum concentration of 3.98 mg/mL was 87.30% with an effective concentration 50 (EC50) of 0.66±0.05 mg/mL. The analgesic effect of ITM was dose-dependent, with inhibition percentages at the dose of 50 mg/kg of 59.82%, that of 100 mg/kg of 64.73% and that of 150 mg/kg of 71.43%. The results on ITM provide a scientific basis for its use in the management of gastric pathologies. Keywords: ITM; Phytochemicals; Antioxidants; Acute toxicity; Antispasmodic; Analgesic.
- Open Access
- 20 February 2025
- Published by Science Publishing Group in Pharmaceutical Science and Technology
- Vol. 9 (1) , 17-26
Formulation of Effervescent Granules Based on Calotropis procera Ait Powder (Apocynaceae) and Zanthoxylum zanthoxyloides Lam (Rutaceae)
Introduction: Sickle cell disease is a genetic disease that affects nearly 5% of the world's population and is particularly prevalent in sub-Saharan Africa. The inaccessibility of modern treatment has led to the development of a phytomedicine called FACA® in Burkina Faso. It is formulated in capsule form and contains a mixture of powdered root barks of Zanthoxylum zanthoxyloides and Calotropis procera . This study aims to propose an alternative, easier-to-administer form for patients who have difficulty swallowing capsules by developing effervescent granules. Materials and methods: Pre-formulation studies focused on analyzing the physicochemical and pharmaco-technical properties of the powder mixture. These included macroscopic and organoleptic aspects, pH, residual moisture content, hygroscopicity, granulometry, and flow. Effervescent granules were formulated and manufactured by the wet granulation method. Five formulations (F1-F5) were produced. Citric acid and sodium bicarbonate were used as effervescent vehicles at a ratio of 1:1.25. PVP was used as a binding agent, sucrose as a sweetener, and cornstarch as a diluent. The granulation liquid was distilled water. The granules produced were evaluated for their physicochemical properties and disintegration time. Results and discussion: the results of the physicochemical and pharmaco-technical characteristics guided the choice of excipients and the manufacturing process. The formulations were beige in color and granular in appearance. THR values were <10%, pH ranged from 5.20 ± 0.29 to 5.91 ± 0.17. They were more or less hygroscopic and presented good rheological properties with an effervescence time satisfying the specifications of the European Pharmacopoeia 11th edition. Conclusion: F4 formulation had the best characteristics and could serve as an alternative to capsules. Indeed, being dispersed in water before administration, these granules could be well tolerated by the gastrointestinal tract and promote a more rapid action of the drug at a time of crisis.
- 20 February 2025
- Published by Science Publishing Group in Pharmaceutical Science and Technology
- Vol. 9 (1) , 17-26
Open AccessFormulation of Effervescent Granules Based on Calotropis procera Ait Powder (Apocynaceae) and Zanthoxylum zanthoxyloides Lam (Rutaceae)
Introduction: Sickle cell disease is a genetic disease that affects nearly 5% of the world's population and is particularly prevalent in sub-Saharan Africa. The inaccessibility of modern treatment has led to the development of a phytomedicine called FACA® in Burkina Faso. It is formulated in capsule form and contains a mixture of powdered root barks of Zanthoxylum zanthoxyloides and Calotropis procera . This study aims to propose an alternative, easier-to-administer form for patients who have difficulty swallowing capsules by developing effervescent granules. Materials and methods: Pre-formulation studies focused on analyzing the physicochemical and pharmaco-technical properties of the powder mixture. These included macroscopic and organoleptic aspects, pH, residual moisture content, hygroscopicity, granulometry, and flow. Effervescent granules were formulated and manufactured by the wet granulation method. Five formulations (F1-F5) were produced. Citric acid and sodium bicarbonate were used as effervescent vehicles at a ratio of 1:1.25. PVP was used as a binding agent, sucrose as a sweetener, and cornstarch as a diluent. The granulation liquid was distilled water. The granules produced were evaluated for their physicochemical properties and disintegration time. Results and discussion: the results of the physicochemical and pharmaco-technical characteristics guided the choice of excipients and the manufacturing process. The formulations were beige in color and granular in appearance. THR values were <10%, pH ranged from 5.20 ± 0.29 to 5.91 ± 0.17. They were more or less hygroscopic and presented good rheological properties with an effervescence time satisfying the specifications of the European Pharmacopoeia 11th edition. Conclusion: F4 formulation had the best characteristics and could serve as an alternative to capsules. Indeed, being dispersed in water before administration, these granules could be well tolerated by the gastrointestinal tract and promote a more rapid action of the drug at a time of crisis.
- Open Access
- 15 December 2023
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 13 (12) , 148-154
Phytochemical profile, acute oral toxicity, antioxidant, and antispasmodic effects of ethyl acetate and aqueous residual fractions of Diospyros mespiliformis Hochst. ex A. DC (Ebenaceae) leaves on isolated duodenum of rat
Introduction: Diospyros mespiliformis Hochst. ex A. Rich (Ebenaceae) is a nutritional, artisanal and medicinal plant. It is used in alternative medicine in Burkina Faso for the treatment of conjunctivitis, menorrhagia, dysentery, and especially diarrhea. Aims: Our study aimed to evaluate the chemical profile, the antioxidant and anti-inflammatory activities, the safety of use, and the spasmolytic effects of the fractions obtained from the aqueous decoction of the leaves of Diospyros mespiliformis. Methods: Phytochemical screening by HPTLC and the determination of compounds of interest were carried out. The antioxidant activity was evaluated according to the ABTS, DPPH, FRAP, and LPO methods. The inhibitory activity of Phospholipase A2 and 15-lipoxygenase was evaluated. Acute oral toxicity was carried out on female mice (NMRI). The ex vivo spasmolytic effect of the fractions was tested on isolated rat duodenum using ACh and BaCl2 as contracting agents. Results: At the end of these tests, the fractions contain flavonoids, tannins, sterols, triterpenes, and saponosides. The content of total phenolics was respectively for the ethyl acetate fraction (EAF) and the residual aqueous fraction (RAF) 84.15±1.73 mg EAT/g and 89.67±2.35 mg EAT/g. That of flavonoids was respectively 45.91 ± 0.98 mg EQ/g and 10.46±0.28 mg EQ/g for the two fractions. The 50% inhibitory concentrations (IC50) of EAF for the ABTS, DPPH, and FRAP tests were 2.26±0.16 μg/mL, 22.34±7.23 μg/mL and 1136.25±0.90 mol EAA/g respectively, and an inhibition % of 43.80 ± 6.31% for LPO. For RAF, the IC50 were in the same range as EAF of 16.82±0.23 μg/mL, 18.58±2.91 μg/mL, 1138.4±1.27 mol EAA/g and an inhibition of 45.14±10.35% for LPO. The fractions had an inhibitory effect on phospholipase A2 compared to Betamethasone. Finally, the most active EAF caused a spasmolytic effect with Emax of 87.4±15.71% and 90.40±7.84%, respectively, during contractions induced by BaCl2 and ACh. Conclusion: Finally, this work provided scientific data and could justify the use of D. mespiliformis leaves in the treatment of diarrhea. Keywords: Diospyros mespiliformis, Leaves, Antioxidants, Anti-inflammatory, Safety of use, Spasmolytic
- 15 December 2023
- Published by Society of Pharmaceutical Tecnocrats in Journal of Drug Delivery and Therapeutics
- Vol. 13 (12) , 148-154
Open AccessPhytochemical profile, acute oral toxicity, antioxidant, and antispasmodic effects of ethyl acetate and aqueous residual fractions of Diospyros mespiliformis Hochst. ex A. DC (Ebenaceae) leaves on isolated duodenum of rat
Introduction: Diospyros mespiliformis Hochst. ex A. Rich (Ebenaceae) is a nutritional, artisanal and medicinal plant. It is used in alternative medicine in Burkina Faso for the treatment of conjunctivitis, menorrhagia, dysentery, and especially diarrhea. Aims: Our study aimed to evaluate the chemical profile, the antioxidant and anti-inflammatory activities, the safety of use, and the spasmolytic effects of the fractions obtained from the aqueous decoction of the leaves of Diospyros mespiliformis. Methods: Phytochemical screening by HPTLC and the determination of compounds of interest were carried out. The antioxidant activity was evaluated according to the ABTS, DPPH, FRAP, and LPO methods. The inhibitory activity of Phospholipase A2 and 15-lipoxygenase was evaluated. Acute oral toxicity was carried out on female mice (NMRI). The ex vivo spasmolytic effect of the fractions was tested on isolated rat duodenum using ACh and BaCl2 as contracting agents. Results: At the end of these tests, the fractions contain flavonoids, tannins, sterols, triterpenes, and saponosides. The content of total phenolics was respectively for the ethyl acetate fraction (EAF) and the residual aqueous fraction (RAF) 84.15±1.73 mg EAT/g and 89.67±2.35 mg EAT/g. That of flavonoids was respectively 45.91 ± 0.98 mg EQ/g and 10.46±0.28 mg EQ/g for the two fractions. The 50% inhibitory concentrations (IC50) of EAF for the ABTS, DPPH, and FRAP tests were 2.26±0.16 μg/mL, 22.34±7.23 μg/mL and 1136.25±0.90 mol EAA/g respectively, and an inhibition % of 43.80 ± 6.31% for LPO. For RAF, the IC50 were in the same range as EAF of 16.82±0.23 μg/mL, 18.58±2.91 μg/mL, 1138.4±1.27 mol EAA/g and an inhibition of 45.14±10.35% for LPO. The fractions had an inhibitory effect on phospholipase A2 compared to Betamethasone. Finally, the most active EAF caused a spasmolytic effect with Emax of 87.4±15.71% and 90.40±7.84%, respectively, during contractions induced by BaCl2 and ACh. Conclusion: Finally, this work provided scientific data and could justify the use of D. mespiliformis leaves in the treatment of diarrhea. Keywords: Diospyros mespiliformis, Leaves, Antioxidants, Anti-inflammatory, Safety of use, Spasmolytic